Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

Aug 01

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. (INO) slipped 1.39% to $1.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.03% to 21,122.45 and Dow Jones Industrial Average falling 0.74% to 44,130.98.

Inovio Pharmaceuticals Inc. closed 86.69% short of its 52-week high of $10.67, which the company reached on August 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.51% to $164.74, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE.AU)$ fell 2.18% to $23.29.

Trading volume (779,081) remained 1.1 million below its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 31, 2025 17:26 ET (21:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2556054854"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556054854\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556054854?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-01 05:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556054854","market":"sh","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. (INO) slipped 1.39% to $1.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.03% to 21,122.45 and Dow Jones Industrial Average  falling 0.74% to 44,130.98. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 86.69% short of its 52-week high of $10.67, which the company reached on August 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.51% to $164.74, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) remained unchanged, and <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> Inc. <a href=\"https://laohu8.com/S/PFE.AU\">$(PFE.AU)$</a> fell 2.18% to $23.29. \n</p>\n<p>\n     Trading volume (779,081) remained 1.1 million below its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 31, 2025 17:26 ET (21:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-08-01 05:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals</a> Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. (INO) slipped 1.39% to $1.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.03% to 21,122.45 and Dow Jones Industrial Average  falling 0.74% to 44,130.98. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 86.69% short of its 52-week high of $10.67, which the company reached on August 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.51% to $164.74, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) remained unchanged, and <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> Inc. <a href=\"https://laohu8.com/S/PFE.AU\">$(PFE.AU)$</a> fell 2.18% to $23.29. \n</p>\n<p>\n     Trading volume (779,081) remained 1.1 million below its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 31, 2025 17:26 ET (21:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INO","symbol_name":"伊诺维奥制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2556054854","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556054854","pubTimestamp":1753997160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 1.39% to $1.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.03% to 21,122.45 and Dow Jones Industrial Average  falling 0.74% to 44,130.98.Inovio Pharmaceuticals Inc. closed 86.69% short of its 52-week high of $10.67, which the company reached on August 1st.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 1.51% to $164.74, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 2.18% to $23.29.Trading volume  remained 1.1 million below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INO":"伊诺维奥制药"},"translate_title":"尽管当天下跌，Inovio Pharmaceuticals Inc.股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1},"content_text":"DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. (INO) slipped 1.39% to $1.42 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.03% to 21,122.45 and Dow Jones Industrial Average  falling 0.74% to 44,130.98. \n\n\n     Inovio Pharmaceuticals Inc. closed 86.69% short of its 52-week high of $10.67, which the company reached on August 1st. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.51% to $164.74, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE.AU)$ fell 2.18% to $23.29. \n\n\n     Trading volume (779,081) remained 1.1 million below its 50-day average volume of 1.8 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 31, 2025 17:26 ET (21:26 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}